The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy

J Transl Med. 2024 Apr 30;22(1):403. doi: 10.1186/s12967-024-05166-y.
No abstract available

Keywords: ROS1; Biomarker; Immunotherapy; Tumor immunogenicity; cancer.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunity / genetics
  • Immunotherapy*
  • Mutation* / genetics
  • Neoplasms* / genetics
  • Neoplasms* / immunology
  • Neoplasms* / therapy
  • Protein-Tyrosine Kinases / genetics
  • Proto-Oncogene Proteins* / genetics

Substances

  • ROS1 protein, human
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases